Massachusetts Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.76M Buy
3,000
+50
+2% +$50.7K 1.2% 29
2025
Q4
$3.17M Buy
2,950
+115
+4% +$110K 1.48% 19
2025
Q3
$2.16M Buy
2,835
+195
+7% +$145K 1.07% 40
2025
Q2
$2.06M Buy
2,640
+35
+1% +$27.2K 1.16% 36
2025
Q1
$2.15M Buy
2,605
+35
+1% +$29.1K 1.48% 27
2024
Q4
$1.98M Buy
2,570
+10
+0.4% +$8.28K 1.22% 36
2024
Q3
$2.27M Buy
2,560
+345
+16% +$310K 1.43% 28
2024
Q2
$2.01M Buy
2,215
+575
+35% +$460K 1.35% 29
2024
Q1
$1.28M Buy
1,640
+275
+20% +$196K 0.9% 49
2023
Q4
$796K Buy
1,365
+785
+135% +$458K 0.64% 61
2023
Q3
$312K Hold
580
0.29% 78
2023
Q2
$272K Buy
+580
New +$243K 0.26% 76

Other funds holding LLY

Massachusetts Wealth Management's LLY Position: Q1 2026 in Review

Massachusetts Wealth Management increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $50.7K and bringing the position to 3,000 shares worth $2.76M. The position accounts for 1.2% of the portfolio, ranked #29.

Massachusetts Wealth Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.17M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Massachusetts Wealth Management held 3,000 shares of Eli Lilly worth $2.76M as of Q1 2026.
  • Massachusetts Wealth Management bought 50 Eli Lilly shares in Q1 2026, an estimated $50.7K.
  • Eli Lilly made up 1.2% of Massachusetts Wealth Management's portfolio in Q1 2026, its #29 holding.
  • Massachusetts Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Massachusetts Wealth Management's Eli Lilly position peaked at $3.17M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Massachusetts Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.